|

Sacubitril-valsartan Clinical Trials

10 actively recruiting trials across 3 locations

Also known as: Entresto

Pipeline

Phase 1: 1Phase 3: 1Phase 4: 4Phase 1/2: 1

Top Sponsors

  • Virginia Commonwealth University1
  • University of Edinburgh1
  • The Cleveland Clinic1
  • Silesian Centre for Heart Diseases1
  • Khawaja Danish Ali1

Indications

  • Heart Disease10
  • Heart Failure4
  • Sacubitril/Valsartan2
  • Cancer2
  • Angiotensin Receptor/Neprilysin Inhibitor1

Other7 trials

Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy
N/A
Sacubitril-valsartan in Patients With Heart Failure.
N/A
Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction
N/A
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Phase 4
The Effect of Sacubitril/valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients with Ischemic Heart Failure with Mid-range Ejection Fraction
Phase 3
Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
Phase 4
Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG Trial
Phase 1

Huntsville, Alabama1 trial

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

Heart Center Research, LLC

Phase 4

Cleveland, Ohio1 trial

Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study

Cleveland Clinic

Phase 4

Richmond, Virginia1 trial

Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan

Virginia Commonwealth University

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.